LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article ; Online: Pneumonitis from immune checkpoint inhibitors and COVID-19

    Giampaolo Tortora / Giovanni Schinzari / Ernesto Rossi

    Journal for ImmunoTherapy of Cancer, Vol 8, Iss

    current concern in cancer treatment

    2020  Volume 2

    Abstract: Pneumonitis is a rare but serious adverse event caused by cancer immunotherapy. The diagnosis between COVID-19-induced pneumonia and immunotherapy-induced pneumonitis may be challenging in the era of COVID-19 outbreak. Some clinical symptoms and ... ...

    Abstract Pneumonitis is a rare but serious adverse event caused by cancer immunotherapy. The diagnosis between COVID-19-induced pneumonia and immunotherapy-induced pneumonitis may be challenging in the era of COVID-19 outbreak. Some clinical symptoms and radiological findings of pneumonitis can be attributed to the coronavirus infection as well as to an immune-related adverse event. Identifying the exact cause of a pneumonitis in patients on treatment with immunotherapy is crucial to promptly start the most appropriate treatment. The proper management of immune checkpoint inhibitors for the risk of pneumonia must take into account a series of parameters. Accurate attention should be payed to symptoms like cough, fever and dyspnea during immunotherapy.
    Keywords Neoplasms. Tumors. Oncology. Including cancer and carcinogens ; RC254-282 ; covid19
    Language English
    Publishing date 2020-11-01T00:00:00Z
    Publisher BMJ Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors

    Sabrina Chiloiro / Antonella Giampietro / Antonio Bianchi / Sara Menotti / Flavia Angelini / Tommaso Tartaglione / Gian Carlo Antonini Cappellini / Federica De Galitiis / Ernesto Rossi / Giovanni Schinzari / Alessandro Scoppola / Alfredo Pontecorvi / Laura De Marinis / Maria Fleseriu

    Journal of Personalized Medicine, Vol 13, Iss 415, p

    Two Sides of the Same Coin?

    2023  Volume 415

    Abstract: Background: Immune checkpoint inhibitor hypophysitis (IIHs) is an emerging problem in cancer patients treated with immune checkpoint inhibitors (ICIs). We aimed to describe the clinical and molecular features of a multicenter series of IIHs. Methods: ... ...

    Abstract Background: Immune checkpoint inhibitor hypophysitis (IIHs) is an emerging problem in cancer patients treated with immune checkpoint inhibitors (ICIs). We aimed to describe the clinical and molecular features of a multicenter series of IIHs. Methods: Demographic and clinical features were retrospectively collected for all cases. Anti-pituitary and anti-hypothalamus autoantibodies were also measured. Results: Nine patients were included. Six patients were treated with nivolumab and three with ipilimumab. Secondary hypoadrenalism was diagnosed in all patients. Pituitary MRI showed pituitary enlargement in two cases and no abnormalities in the other seven. Anti-pituitary antibodies were positive in 57.1% of cases and anti-hypothalamus antibodies in 85.7% of cases. Multidisciplinary treatments were established by a neuroendocrinologist and oncologists: all patients were treated with hydrocortisone replacement; ICI was withdrawn in two cases. At follow-up, hypoadrenalism persisted in all cases. Pituitary enlargement on MRI spontaneously recovered in the two affected patients. We found that the typical features of hypophysitis involved more frequently females and patients treated with ipilimumab. Conclusions: Although this study did not clarify if autoimmune secondary hypoadrenalism and ICI hypophysitis on brain imaging are two sides of the same disease, our preliminary data underline the need for molecular studies of IIHs and of autoimmune ICIs-related hypopituitarism.
    Keywords hypophysitis ; autoimmune disease ; chemotherapy ; melanoma ; Medicine ; R
    Subject code 616 ; 610
    Language English
    Publishing date 2023-02-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions

    Alessandro Di Stefani / Simone Cappilli / Giovanni Cuffaro / Bruno Fionda / Monica Maria Pagliara / Andrea Paradisi / Costantino Ricci / Ernesto Rossi / Maria Grazia Sammarco / Giovanni Schinzari / Luca Tagliaferri / Maria Antonietta Blasi / Elisa Cinotti / Alessandro Moro / Gustavo Savino / Mariano Suppa / Ketty Peris

    Diagnostics, Vol 13, Iss 23, p

    2023  Volume 3590

    Abstract: Background: Periocular malignancies may be clinically different from the examples arising at other sites, with possible delayed diagnosis and greater challenges for treatment and repair. Line-field confocal optical coherence tomography (LC-OCT) is a ... ...

    Abstract Background: Periocular malignancies may be clinically different from the examples arising at other sites, with possible delayed diagnosis and greater challenges for treatment and repair. Line-field confocal optical coherence tomography (LC-OCT) is a recently developed technique characterized by an unprecedented capacity to acquire high-definition images in vertical and horizontal modes. In this study, we aimed to investigate the LC-OCT morphological features of a series of eyelid skin lesions, correlating them to histopathological findings. Methods: Patients with biopsy-proven equivocal skin lesion in the eyelid area, previously investigated by means of LC-OCT, were included in the study. Percentage overall agreement was estimated for LC-OCT and histopathological diagnosis for study cases. Results: A total of 51 patients (28 women, 23 men; mean age 66.4 years old), for a total of 51 skin lesions, were assessed. The histopathological diagnosis consisted of 30 malignant and 21 benign tumors. Different entities were characterized by peculiar findings in LC-OCT, alike to histopathological features, allowing for an accurate “in vivo” classification in almost all cases, with a diagnostic concordance with histopathology of 92.1% (47/51). Conclusions: By integrating this new imaging technique into the assessment of suspicious tumors in this area, diagnostic accuracy may increase, improving strategies adopted in multidisciplinary meetings and patient-centered care.
    Keywords melanoma ; histology of the skin ; line-field confocal optical coherence tomography ; eyelid ; epithelial carcinomas ; non-invasive diagnosis ; Medicine (General) ; R5-920
    Subject code 616
    Language English
    Publishing date 2023-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Clinical and ultrasonographic features of choroidal metastases based on primary cancer site

    Maria Antonietta Blasi / Martina Maceroni / Carmela Grazia Caputo / Maria Grazia Sammarco / Andrea Scupola / Jacopo Lenkowicz / Giovanni Schinzari / Ernesto Rossi / Monica Maria Pagliara

    PLoS ONE, Vol 16, Iss 3, p e

    Long-term experience in a single center.

    2021  Volume 0249210

    Abstract: Introduction and purpose Choroidal metastases (CM) are the most common intraocular malignancies. With longer survival rates for cancer patients, CM will be increasingly encountered. We evaluated clinical and ultrasonographic (US) characteristics of CM in ...

    Abstract Introduction and purpose Choroidal metastases (CM) are the most common intraocular malignancies. With longer survival rates for cancer patients, CM will be increasingly encountered. We evaluated clinical and ultrasonographic (US) characteristics of CM in order to identify diagnostic biomarkers that correlate with the primary tumor site. Methods The medical records of all patients with CM evaluated at the Ocular Oncology Unit between February 2010 and March 2020 were analyzed. Results 82 eyes of 70 patients were included. The primary cancer site was lung in 26 patients (37%), breast in 23 (33%), kidney in 9 (13%), gastrointestinal in 5 (7%), thyroid in 5 (7%), parathyroids and prostate respectively in 2 (3%). Fifty-five patients (78%) had other systemic metastases at the time of ocular diagnosis. Ten (14%) patients had no history of primary cancer. Bilateral CM were found in 20 patients (29%); fifty-six eyes (68%) had a single CM. The epicenter of CM was predominantly macula (43 eyes, 52%). The mean thickness was 4,1 mm (range 1,8-12,3). US structure was inhomogeneous in 67 eyes (82%). Reflectivity was mainly medium (39%) and medium-low (39%). In particular, CM from lung cancer showed lower reflectivity than those from the breast (p = 0,02). CM deriving from lung cancer were typically dome-shaped, whereas CM originating from breast were characteristically plateau shaped (p = 0,02). Seventy-four (91%) eyes presented fluid on optical coherence tomography. Conclusion We significatively found that CM from lung cancer generally appear dome-shaped with medium-low internal reflectivity, whereas those from breast cancer typically present a plateau appearance and higher internal reflectivity. Though it is hard to identify the site of the primary tumor relying exclusively on clinical and US aspects, morphology and internal reflectivity can be considered as diagnostic biomarkers. Thus, the origin of the primary tumor can be suspected by integrating a constellation of findings.
    Keywords Medicine ; R ; Science ; Q
    Subject code 610
    Language English
    Publishing date 2021-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy

    Vincenzo Fiorentino / Maurizio Martini / Marco Dell’Aquila / Teresa Musarra / Ersilia Orticelli / Luigi Maria Larocca / Ernesto Rossi / Angelo Totaro / Francesco Pinto / Niccolò Lenci / Valerio Di Paola / Riccardo Manfredi / Pier Francesco Bassi / Francesco Pierconti

    Diagnostics, Vol 11, Iss 10, p

    2021  Volume 10

    Abstract: Biopsy proven Gleason score is essential to decide treatment modalities for prostate cancer, either surgical (radical prostatectomy) or non-surgical (active surveillance, watchful waiting, radiation therapy and hormone therapy). Several studies indicated ...

    Abstract Biopsy proven Gleason score is essential to decide treatment modalities for prostate cancer, either surgical (radical prostatectomy) or non-surgical (active surveillance, watchful waiting, radiation therapy and hormone therapy). Several studies indicated that biopsy proven Gleason score may underestimate Gleason score at radical prostatectomy, hence we aimed to calculate the minimum length of biopsy cores needed to have Gleason score agreement. We evaluated 115 prostate cancer patients who underwent multiparametric magnetic resonance/transperineal ultrasonography fusion biopsy and subsequently, radical prostatectomy. Biopsy proven Gleason score was consistent with Gleason score at subsequent radical prostatectomy in 82.6% of patients, while in 17.4% of patients, Gleason score was higher at radical prostatectomy. Gleason score agreement showed a strong direct association with a ratio > 0.05 between the total volume of biopsies performed in tumor area and the volume of the corresponding tumor at radical prostatectomy. A significant association was also found with a ratio ≥ 0.0034 between the tumor volume in the biopsy and the volume of the corresponding tumor at radical prostatectomy and with a ratio ≥ 0.086 between the tumor volume in the biopsy and the total volume of biopsies performed in the tumor area. These results could be exploited to calculate the minimum length of biopsy cores needed to have a correct Gleason score estimation and therefore be used in fusion targeted biopsies with volume adjustments.
    Keywords active surveillance ; Gleason score ; needle biopsy ; prostate cancer ; radical prostatectomy ; Medicine (General) ; R5-920
    Subject code 616
    Language English
    Publishing date 2021-12-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Conjunctival Melanoma

    Ernesto Rossi / Giovanni Schinzari / Brigida Anna Maiorano / Monica Maria Pagliara / Alessandro Di Stefani / Emilio Bria / Ketty Peris / Maria Antonietta Blasi / Giampaolo Tortora

    International Journal of Molecular Sciences, Vol 20, Iss 21, p

    Genetic and Epigenetic Insights of a Distinct Type of Melanoma

    2019  Volume 5447

    Abstract: Conjunctival melanoma (CjM) is a rare, primary cancer of the ocular region. Genetic and epigenetic characteristics of conjunctival melanoma have not been completely elucidated yet. Conjunctival melanoma presents similarities with cutaneous melanoma, with ...

    Abstract Conjunctival melanoma (CjM) is a rare, primary cancer of the ocular region. Genetic and epigenetic characteristics of conjunctival melanoma have not been completely elucidated yet. Conjunctival melanoma presents similarities with cutaneous melanoma, with substantial differences in the biological behavior. We reviewed the genetic and epigenetic insights of CjM involved in invasion and metastatic spread. CjM is commonly characterized by mutations of v-raf murine sarcoma viral oncogene homolog B1 ( BRAF ), neurofibromin 1 ( NF1 ) and telomerase reverse transcriptase ( TERT ), high expression of mammalian target of rapamycin (mTOR) and heat shock protein 90 (HSP90), frequent phosphatase and tensin homolog (PTEN) loss and upregulation of specific miRNAs. These features should identify CjM as a distinct subset of melanoma with its own profile, which is more similar to cutaneous melanoma than mucosal melanoma and remarkably different from uveal melanoma.
    Keywords conjunctival ; melanoma ; braf ; nras ; nf1 ; ezh2 ; mirna ; genetic ; Biology (General) ; QH301-705.5 ; Chemistry ; QD1-999
    Subject code 570
    Language English
    Publishing date 2019-10-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article ; Online: Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma

    Gianluca Ianiro / Ernesto Rossi / Andrew M. Thomas / Giovanni Schinzari / Luca Masucci / Gianluca Quaranta / Carlo Romano Settanni / Loris Riccardo Lopetuso / Federica Armanini / Aitor Blanco-Miguez / Francesco Asnicar / Clarissa Consolandi / Roberto Iacovelli / Maurizio Sanguinetti / Giampaolo Tortora / Antonio Gasbarrini / Nicola Segata / Giovanni Cammarota

    Nature Communications, Vol 11, Iss 1, Pp 1-

    2020  Volume 6

    Abstract: Tyrosine kinase inhibitors (TKIs) have improved the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC), however TKI-related diarrhoea is a common and serious adverse effect. Here the authors show in a randomized clinical trial that ...

    Abstract Tyrosine kinase inhibitors (TKIs) have improved the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC), however TKI-related diarrhoea is a common and serious adverse effect. Here the authors show in a randomized clinical trial that faecal microbiota transplantation from healthy donors can improve TKI-induced diarrhoea in patients with mRCC.
    Keywords Science ; Q
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher Nature Publishing Group
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma

    Gianluca Ianiro / Ernesto Rossi / Andrew M. Thomas / Giovanni Schinzari / Luca Masucci / Gianluca Quaranta / Carlo Romano Settanni / Loris Riccardo Lopetuso / Federica Armanini / Aitor Blanco-Miguez / Francesco Asnicar / Clarissa Consolandi / Roberto Iacovelli / Maurizio Sanguinetti / Giampaolo Tortora / Antonio Gasbarrini / Nicola Segata / Giovanni Cammarota

    Nature Communications, Vol 11, Iss 1, Pp 1-

    2020  Volume 6

    Abstract: Tyrosine kinase inhibitors (TKIs) have improved the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC), however TKI-related diarrhoea is a common and serious adverse effect. Here the authors show in a randomized clinical trial that ...

    Abstract Tyrosine kinase inhibitors (TKIs) have improved the clinical outcomes of patients with metastatic renal cell carcinoma (mRCC), however TKI-related diarrhoea is a common and serious adverse effect. Here the authors show in a randomized clinical trial that faecal microbiota transplantation from healthy donors can improve TKI-induced diarrhoea in patients with mRCC.
    Keywords Science ; Q
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology

    Valentina Lancellotta / Jose Luis Guinot / Bruno Fionda / Agata Rembielak / Alessandro Di Stefani / Stefano Gentileschi / Francesco Federico / Ernesto Rossi / Benjamin Guix / Artur Jan Chyrek / Arenas Meritxell / Silvia Villalba / Giuseppe Colloca / Nicola Dinapoli / Carlotta Masciocchi / Jacopo Lenkowicz / Nicola Capocchiano / Andrea Damiani / Vincenzo Valentini /
    Gyorgy Kovacs / Luca Tagliaferri

    Journal of Contemporary Brachytherapy, Vol 12, Iss 2, Pp 105-

    The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer

    2020  Volume 110

    Keywords brachytherapy ; ontology ; skin cancer ; Medicine ; R
    Language English
    Publishing date 2020-04-01T00:00:00Z
    Publisher Termedia Publishing House
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2)

    Melissa Bersanelli / Elena Verzoni / Alessio Cortellini / Raffaele Giusti / Lorenzo Calvetti / Paola Ermacora / Marilena Di Napoli / Annamaria Catino / Valentina Guadalupi / Giorgia Guaitoli / Vieri Scotti / Francesca Mazzoni / Antonello Veccia / Pamela Francesca Guglielmini / Fabiana Perrone / Marco Maruzzo / Ernesto Rossi / Chiara Casadei / Vincenzo Montesarchio /
    Francesco Grossi / Mimma Rizzo / Maria Grazia Travagliato Liboria / Manlio Mencoboni / Fable Zustovich / Lucia Fratino / Caterina Accettura / Saverio Cinieri / Andrea Camerini / Mariella Sorarù / Paolo Andrea Zucali / Serena Ricciardi / Antonio Russo / Giorgia Negrini / Maria Chiara Banzi / Gaetano Lacidogna / Giuseppe Fornarini / Letizia Laera / Claudia Mucciarini / Matteo Santoni / Claudia Mosillo / Andrea Bonetti / Lucia Longo / Donata Sartori / Editta Baldini / Michele Guida / Mauro Iannopollo / Roberto Bordonaro / Maria Francesca Morelli / Pierosandro Tagliaferri / Massimiliano Spada / Anna Ceribelli / Rosa Rita Silva / Franco Nolè / Giordano Beretta / Petros Giovanis / Daniele Santini / Stefano Luzi Fedeli / Oriana Nanni / Evaristo Maiello / Roberto Labianca / Carmine Pinto / Alberto Clemente / Michele Tognetto / Ugo De Giorgi / Sandro Pignata / Massimo Di Maio / Sebastiano Buti / Diana Giannarelli

    EClinicalMedicine, Vol 61, Iss , Pp 102044- (2023)

    final results of the multicentre, prospective, observational studyResearch in context

    2023  

    Abstract: Summary: Background: The prospective multicentre observational INVIDIa-2 study investigated the clinical effectiveness of influenza vaccination in patients with advanced cancer receiving immune checkpoint inhibitors (ICI). In this secondary analysis of ... ...

    Abstract Summary: Background: The prospective multicentre observational INVIDIa-2 study investigated the clinical effectiveness of influenza vaccination in patients with advanced cancer receiving immune checkpoint inhibitors (ICI). In this secondary analysis of the original trial, we aimed to assess the outcomes of patients to immunotherapy based on vaccine administration. Methods: The original study enrolled patients with advanced solid tumours receiving ICI at 82 Italian Oncology Units from Oct 1, 2019, to Jan 31, 2020. The trial's primary endpoint was the time-adjusted incidence of influenza-like illness (ILI) until April 30, 2020, the results of which were reported previously. Secondary endpoints (data cut-off Jan 31, 2022) included the outcomes of patients to immunotherapy based on vaccine administration, for which the final results are reported herein. A propensity score matching by age, sex, performance status, primary tumour site, comorbidities, and smoking habits was planned for the present analysis. Only patients with available data for these variables were included. The outcomes of interest were overall survival (OS), progression-free survival (PFS), objective response rate (ORR), and disease-control rate (DCR). Findings: The original study population consisted of 1188 evaluable patients. After a propensity score matching, 1004 patients were considered (502 vaccinated and 502 unvaccinated), and 986 of them were evaluable for overall survival (OS). At the median follow-up of 20 months, the influenza vaccination demonstrated a favourable impact on the outcome receiving ICI in terms of median OS [27.0 months (CI 19.5–34.6) in vaccinated vs. 20.9 months (16.6–25.2) in unvaccinated, p = 0.003], median progression-free survival [12.5 months (CI 10.4–14.6) vs. 9.6 months (CI 7.9–11.4), p = 0.049], and disease-control rate (74.7% vs. 66.5%, p = 0.005). The multivariable analyses confirmed the favourable impact of influenza vaccination in terms of OS (HR 0.75, 95% C.I. 0.62–0.92; p = 0.005) and DCR (OR 1.47, 95% C.I. ...
    Keywords Influenza-like illness ; Influenza vaccination ; Flu vaccine ; Immune checkpoint inhibitors ; Cancer patients ; ICI ; Medicine (General) ; R5-920
    Subject code 610
    Language English
    Publishing date 2023-07-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top